RxDoctor Payments Data

Jared Christensen, MD

Vascular & Interventional Radiology · Ann Arbor, MINPI 1053397075

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,912 of the $6,271 with a category attached, or 78.3%. Genentech USA, Inc. accounts for 78.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $3,890 and has fallen 95.1% since, to $191 in 2024.

$6,271in general payments, 2019–2025

Across 24 payments — averaging $261.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$5K
  • Sirtex Medical Inc$922
  • Abbott$126
  • Medtronic$91
  • Boston Scientific$90
  • Merck$65
  • plus $72 from 3 others

What the payments were for

  • Consulting fees$4,91278%
  • Travel & lodging$72011%
  • Food & beverage$64010%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.3$4,905
Sirtex Medical Inc7$922
Abbott1$126
Medtronic(2 entities)5$91
Boston Scientific2$90
Merck3$65
Abiomed1$39
Penumbra, Inc.1$27
Z-medica, LLC1$7

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,271 in reported general payments places this provider in the 70th percentile of 118 vascular & interventional radiology providers in Michigan.

See all vascular & interventional radiology providers in Michigan

Medicare billing

Part B allowed, 2024
$50,903
Medicare patients
153
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →